Risk and special populations
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
identifying factors
32233642 2020. Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus
32232218 2020. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis
32304772 ä. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019�From a Nationwide Analysis in China
32118640 ä. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease
Frailty
32268300 2020. Biomarkers of biological age as predictors of COVID-19 disease severity
32339960 2020. Clinical characteristics of older patients infected with COVID-19: A descriptive study
32331795 ä. Afectacion clinica y sintomatoligica en pacientes mayores de 65 anos por COVID-19
32269670 2020. Canadian Geriatrics Society COVID-19 Recommendations for Older Adults What Do Older Adults Need To Know?
Comorbidity
32267833 2020. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis
Diabetes, Obesity, low androgens
32249357 ä. Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic
32345580 2020. Diabetes and covid-19: a global health challenge
32345579 2020. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
ACEi ARBs
32363137 ä. Anti-RAS drugs and SARS-CoV-2 infection
32370986 ä. Renin-angiotensin-aldosterone system and COVID-19 infection
32286678 2020. Inhibitors of the renin-angiotensin system: The potential role in the pathogenesis of COVID-19
Heart
32331955 ä. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis
32326691 2020. Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction
32277299 2020. Perspective: cardiovascular disease and the Covid-19 pandemic
32293003 ä. Hypertension, the renin?angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19: European Society of Hypertension COVID-19 Task Force Review of Evidence
32335068 ä. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock
Kidney, Hemodialysis
32240718 ä. COVID-19 in Hemodialysis Patients: A Report of 5 Cases
32276031 ä. COVID-19 and Kidney Failure in the Acute Care Setting: Our Experience From Seattle
Gynecology, Obstetrics, Pregnancy, Neonate
32105680 ä. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know
32363337 ä. Severe ARDS in COVID-19-infected pregnancy: obstetric and intensive care considerations
32363336 ä. Two cases of coronavirus 2019-related cardiomyopathy in pregnancy
32292903 ä. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals
C7104131 ä. Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis
32333857 ä. Coronavirus disease 2019 in pregnancy: consider thromboembolic disorders and thromboprophylaxis
32311350 ä. COVID19 during pregnancy: a systematic review of reported cases
32335053 ä. Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 cases
32360108 ä. Maternal Death Due to COVID-19 Disease
32348744 ä. Maternal Deaths with Covid19: a different outcome from mid to low resource countries?
32245738 2020. Primer caso de infeccion neonatal por SARS-CoV-2 en Espana
32363217 ä. First case of neonatal infection due to COVID 19 in Spain?
32341945 ä. COVID-19: Fever syndrome and neurological symptoms in a neonate?
Cancer
32278878 ä. French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak
32345594 2020. Patients with Cancer Appear More Vulnerable to SARS-COV-2: A Multicenter Study during the COVID-19 Outbreak
On immunomodulators: rheumatic, transplant, dermatology, neurology
32264666 2020. Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon
32363045 ä. Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients
HIV
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19
other pharmacology
Drug abuse
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19
modifiable - tobacco
32303807 ä. Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic
indoor livin ppl
Psychiatry
32294689 2020. Schizophrenia and COVID-19: risks and recommendations
32371563 2020. Asthma increases risk of severity of COVID-19
32360479 ä. 2019 novel coronavirus disease (COVID-19) in hemodialysis patients: a report of two cases
32360811 ä. Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts
32334081 ä. HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN
32276139 2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
32276140 2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
32249918 ä. Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study
32215613 ä. Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System?a Call for Epidemiologic Investigations
32182347 ä. Perinatal Transmissionof COVID-19 Associated SARS-CoV-2:Should We Worry?
32161941 ä. A case report of neonatal COVID-19 infection in China
32119083 ä. A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery
32271368 ä. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission
32270178 ä. Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV
32353114 ä. Throat Wash Testing and COVID-19 Disease: Should We Put Our Money Where Our Mouth Is?
32339215 ä. Clinical impact of renin-angiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for COVID-19
32337584 ä. First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit
32297925 ä. Sequential analysis of viral load in a neonate and her mother infected with SARS-CoV-2
32278081 ä. Association of COVID-19 infection with pregnancy outcomes in healthcare workers and general women
32304745 ä. Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China
32161990 ä. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
32328736 ä. No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity
32376643 2020. Postpartum exacerbation of antenatal COVID-19 pneumonia in 3 women
32332039 2020. Renin-angiotensin-aldosterone system inhibitors and COVID-19
32357998 2020. Cardiac considerations in patients with COVID-19
32332038 2020. Asthma and COVID-19
32264922 2020. COVID-19 and the RAAS?a potential role for angiotensin II?
32291526 2020. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB
32350632 2020. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty
32219626 ä. Experience of Clinical Management for Pregnant Women and Newborns with Novel Coronavirus Pneumonia in Tongji Hospital, China
32300516 ä. Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times
32247213 2020. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)
32298981 2020. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
32283499 2020. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
32334395 ä. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia ? A systematic review, meta-analysis, and meta-regression?
32228738 ä. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease
32213760 2020. Facts and reflections on COVID-19 and anti-hypertensives drugs
32303915 ä. Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
C7143201 ä. Preventive measures and management of COVID-19 in pregnancy
32323279 2020. Renin-Angiotensin-System (RAS) und COVID-19 - Zur Verordnung von RAS-Blockern
32256706 2020. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
32256705 2020. Associations between immune-suppressive and stimulating drugs and novel COVID-19?a systematic review of current evidence
32328575 ä. Age, frailty and diabetes ? triple jeopardy for vulnerability to COVID-19 infection
32322805 ä. SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV
32372857 2020. COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: ?what the bleep do we know??
32250244 2020. Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients
32134381 2020. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China
32324118 2020. Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States
32232395 ä. Initial COVID-19 affecting cardiac patients in China
32324223 ä. Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence
32324222 ä. Switching to another antihypertensive effective drug when using ACEIs/ARBs to treat arterial hypertension during COVID-19
32236478 ä. Speculation is not evidence: antihypertensive therapy and COVID-19
32286607 ä. Might renin?angiotensin system blockers play a role in the COVID-19 pandemic?
32344292 2020. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors
32305831 ä. Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment
32328850 ä. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening
32322046 ä. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China
32296994 ä. The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could lead to overlapping treatments
C7141546 ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?
32345527 ä. Smoking Habit and Hospitalization for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Related Pneumonia: the unsolved paradox behind the evidence
32307204 ä. Intrapartum care of women with COVID-19: A practical approach
32278619 ä. The novel coronavirus (2019-nCoV) in pregnancy: What we need to know
32217650 2020. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
32269089 2020. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
32269087 ä. Novel Coronavirus Infection in Newborn Babies Under 28 Days in China
32269088 2020. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
32341104 2020. Cardiovascular comorbidity and its impact on patients with Covid-19
32350104 ä. COVID-19 and Nicotine as a Mediator of ACE-2
32341101 2020. COVID-19 and Smoking Is Nicotine the Hidden Link?
32312864 ä. Association between ages and clinical characteristics and outcomes of coronavirus disease 2019
32279905 ä. Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Renal Failure Patients: A Potential Covert Source of Infection
32284245 ä. The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is ?Safe Better than Sorry??
32317180 ä. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China
32345072 2020. The role of essential organ-based comorbidities in the prognosis of COVID-19 infection patients
32238084 2020. Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review
32222253 2020. COVID-19: lessons from the Italian reproductive medical experience
32285380 ä. Clinical characteristics of 19 neonates born to mothers with COVID-19
32266184 2020. Infants Born to Mothers With a New Coronavirus (COVID-19)
32323577 ä. What the oncologist needs to know about COVID-19 infection in cancer patients
32322107 2020. SARS-CoV-2 Infection in Pregnancy ? a Review of the Current Literature and Possible Impact on Maternal and Neonatal Outcome
32357575 2020. COVID-19: A Geriatric Emergency
32357582 2020. Ageing and COVID-19: What is the Role for Elderly People?
32274617 2020. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes
32199996 2020. Infection par le SARS-CoV-2 chez les femmes enceintes: etat des connaissances et proposition de prise en charge par CNGOF
32244059 ä. SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes
32302703 ä. Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment
32292696 ä. COVID-19 Infection Unmasking Brugada Syndrome
32277387 ä. Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation
32325028 ä. G6PD deficiency in COVID-19 pandemic: ?a ghost in the ghost?
32274522 ä. Inhibitors of the renin-angiotensin system and SARS-CoV-2 infection
32266708 ä. Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension
32231220 ä. Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension
32341442 ä. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors?lessons from available evidence and insights into COVID-19
32275190 2020. Chronic Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Is High Among Intensive Care Unit Patients With Non?COVID-19 Sepsis but Carries a Moderately Increased Risk of Death
32342146 ä. COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males?
32342336 ä. Prevention and Control of COVID-19 in Chronic Kidney Disease
32238615 2020. Perinatal-Neonatal Management of COVID-19 Infection - Guidelines of the Federation of Obstetric and Gynecological Societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP)
32146921 ä. COVID-19 and gender-specific difference: Analysis of public surveillance data in Hong Kong and Shenzhen, China, from January 10 to February 15, 2020
32279693 ä. Impact of COVID-19 infection on pregnancy outcomes and the risk of maternal-to-neonatal intrapartum transmission of COVID-19 during natural birth
32336303 ä. Risk factors for severe COVID-19 illness in healthcare workers: Too many unknowns
32307025 ä. Could COVID-19 represent a negative prognostic factor in patients with stroke?
